baber/WOPTO huggingface dataset:
Patent NZ-551633-A (NZ)
Title: Security module component
Inventor: KUDELSKI ANDRE
IPC: G06K19/00
Filed: 2005-06-02
Abstract: Component of a security module comprises at least two processors linked through an exchange memory and by a first non-volatile programmable and erasable memory. The first processor has an interface bus with the exterior of the component and is connected to a first random access memory and to a first read only memory. The second processor is connected to a second random access memory and to a second read only memory as well as to a second non-volatile programmable and erasable memory. The first and second random access memories are used for temporary storage of data in process. The first non-volatile programmable and erasable memory of the first processor have read only access for the first processor and the second processor has read and write access on the first non-volatile programmable and erasable memory of the first processor. The exchange memory consists of a random access memory intended for temporary data storage. The exchange memory is equipped with two ports, each configured in read and write, one of which is connected to the first processor and the other to the second processor. All secured operations are managed and executed by the second processor.
Patent NZ-552962-A (NZ)
Title: System and method for diversity interleaving
Inventor: WANG MICHAEL MAO
IPC: H04L1/00
Filed: 2005-07-29
Abstract: A method for interleaving is disclosed. The method comprises: placing turbo encoded code bits into groups according to a bit order; and shuffling the turbo encoded code bits within each group according to a group bit order for the given group. Adjacent turbo encoded code bits are mapped into different constellation symbols.
Patent NZ-566253-A (NZ)
Title: Pulse tube cooler having 1/4 wavelength resonator tube instead of reservoir
Inventor: GEDEON DAVID R
IPC: F25B9/00
Filed: 2006-06-01
Abstract: An improved pulse tube cooler having a resonator tube connected in place of a compliance volume or reservoir. The resonator tube has a length substantially equal to an integer multiple of 1/4 wavelength of an acoustic wave in the working gas within the resonator tube at its operating frequency, temperature and pressure. Preferably, the resonator tube is formed integrally with the inertance tube as a single, integral tube with a length approximately 1/2 of that wavelength. Also preferably, the integral tube is spaced outwardly from and coiled around the connection of the regenerator to the pulse tube at a cold region of the cooler and the turns of the coil are thermally bonded together to improve heat conduction through the coil.
Patent NZ-576305-A (NZ)
Title: Antimicrobial composition useful for preserving wood comprising tebuconazole and copper 8-hydroxyquinoline
Inventor: ASHMORE JOHN WILLIAM
IPC: A01N33/04
Filed: 2006-06-08
Abstract: Disclosed is a synergistic antimicrobial composition comprising a tebuconazole and copper 8-hydroxyquinoline which is use to preserve wood. (62) Divided Out of 563783
Patent NZ-576361-A (NZ)
Title: Solar energy harvester with thermal absorber and transparent casing
Inventor: MITCHELL KEITH
IPC: F24S23/30
Filed: 2007-09-28
Abstract: A solar energy harvesting apparatus including a body supporting a thermal absorber (64) for harvesting solar energy. The thermal absorber (64) comprises a moulded plastic absorber body, a photovoltaic element (65) to which it is thermally bonded and a mounting for engagement with a substrate such as a roof. The absorber (64) further comprises a connector selected to integrate the absorber (64) with other solar energy harvesting apparatus to for a solar water system and an electrical connector to the photovoltaic element (65). This thermal absorber (64) is configured to thermally absorb broadband solar radiation. The body of the apparatus includes a transparent front face (63) enclosing both the absorber (64) and the photovoltaic element (65).
Patent NZ-586813-A (NZ)
Title: Emulsifying systems for frozen food products and methods of preparation thereof
Inventor: NORN VIGGO CREEMERS
IPC: A23L29/10
Filed: 2006-11-27
Abstract: Disclosed is an emulsifying system comprising a 2-propylene glycol monoester of a fatty acid (2-PGME) and a 1-propylene glycol monoester of a fatty acid (1-PGME), wherein the emulsifying system further comprises monoglycerides and diglycerides and wherein the ratio by weight between the monoglyceride and the diglyceride is at most 50:50. Also disclosed are frozen food products comprising said emulsifying system.
Patent NZ-588277-A (NZ)
Title: Portable navigation device, portable electronic communications apparatus, and method of generating radio data system information therefor
Inventor: KAMALSKI THEO
IPC: G01C21/36
Filed: 2008-05-29
Abstract: A portable navigation device and a method of generating Radio Data System information, is disclosed. The portable navigation device comprises: a processing resource operably coupled to a Radio Data System communications unit and a location determination unit, where the processing resource supports a country code selector; and a data store capable of storing Radio Data System country code data, where the data store is operably coupled to the processing resource. The processing resource determines a first country associated with location data generated, when in use, by the location determination unit. The country code selector identifies a first country code from the country code data that does not correspond to the first country associated with the location data and a second country neighbouring the first country. The processing resource uses the first country code to generate a Programme Identification code.
Patent NZ-594347-A (NZ)
Title: Antibodies against human tweak and uses thereof
Inventor: BAEHNER MONIKA
IPC: A61K39/395
Filed: 2010-03-30
Abstract: Disclosed is an antibody binding to human TWEAK, characterized by comprising CDR1H of SEQ ID NO:22, CDR2H of SEQ ID NO:23, CDR3H of SEQ ID NO:24 and CDR1L of SEQ ID NO:18, CDR2L of SEQ ID NO:19, CDR3L of SEQ ID NO:20, or by comprising CDR1H of SEQ ID NO:22, CDR2H of SEQ ID NO:74, CDR3H of SEQ ID NO:24 and CDR1L of SEQ ID NO:18, CDR2L of SEQ ID NO:19, CDR3L of SEQ ID NO:20, or by comprising CDR1H of SEQ ID NO:22, CDR2H of SEQ ID NO:75, CDR3H of SEQ ID NO:24 and CDR1L of SEQ ID NO:18, CDR2L of SEQ ID NO:19, CDR3L of SEQ ID NO:20. Also disclosed is the use of the antibody in the manufacture of a medicament for the treatment of cancer.
Patent NZ-596856-A (NZ)
Title: Pepper hybrid ps09943431
Inventor: MCCARTHY WILLIAM
IPC: A01H5/08
Filed: 2011-12-02
Abstract: Provided is a pepper plant, comprising at least a first set of the chromosomes of pepper line SMR 99-1275, a sample of seed of said line having been deposited under ATCC Accession Number PTA-11520. Further provided is a hybrid line PS09943431 having been deposited under ATCC Accession Number PTA-11519.
Patent NZ-600104-A (NZ)
Title: Novel viral vector construct for neuron specific optimized continuous DOPA synthesis in vivo
Inventor: BJORKLUND TOMAS
IPC: A61K48/00
Filed: 2010-11-09
Abstract: 600104 Disclosed is a one-vector expression system comprising: a first and a second expression cassette, wherein said first expression cassette comprises a nucleotide sequence comprising a first promoter sequence operably linked to a first nucleotide sequence, said first nucleotide sequence encoding a GTP cyclohydrolase 1 (GCH1; EC 3.5.4.16) polypeptide or a biologically active fragment or variant thereof, and wherein said second expression cassette comprises a nucleotide sequence comprising a second promoter sequence operably linked to a second nucleotide sequence said second nucleotide sequence encoding a tyrosine hydroxylase (TH; EC 1.14.16.2) polypeptide or a biologically active fragment or variant thereof, and wherein the vector is an adeno associated vector (AAV) and wherein said second nucleotide sequence is operably linked to a Woodchuck hepatitis virus post-transcriptional regulatory element (WPRE), and wherein both said first and said second promoter are Synapsin1 promoters.
Patent NZ-600710-A (NZ)
Title: A bale assembly for restraining animals with a clutch that locks in position using biased ball roller bearings acting against bracing fingers
Inventor: LINNAN JOHN PATRICK
IPC: A01K1/00
Filed: 2012-06-18
Abstract: Disclosed is a bale assembly for controlling the movement of at least one portion of an animal for easier assessment and treatment of the animal. The bale assembly comprises at least one movable member for restricting the movement of the at least one portion of the animal, a shaft for transmitting an input force directly or indirectly to the at least one movable member, and a clutch for restricting the movement of the shaft. The clutch has a casing, a bracing member, and movement restricting means. When in an active condition, the input force is applied to the shaft to overcome resistance of the bracing member and the movement restricting means to enable movement of the shaft, and thereby enable movement of the at least one movable member. In an inactive condition, the force is removed from the shaft, and the movement restricting means abut the bracing member, which in turn abuts the casing to prevent further movement of the shaft, and thereby prevents movement of the at least one movable member by the animal.
Patent NZ-608814-A (NZ)
Title: Novel modulators and methods of use
Inventor: STULL ROBERT A
IPC: C07K16/40
Filed: 2011-09-02
Abstract: Discloses an isolated anti-CD46 antibody or immunoreactive fragment thereof, wherein the antibody or immunoreactive fragment is selected from the group consisting of SC1.N29 antibody, SC1.N35 antibody, SC1.N50 antibody, SC1.N53 antibody, SC1.N71 antibody, SC1.N91 antibody, SC1.N106 antibody, SC1.N122.1 antibody, SC1.N149 antibody, SC1.N7 antibody, SC1.N54 antibody, SC1.N56 antibody, SC1.N60 antibody, SC1.N66 antibody, SC1.N77 antibody, SC1.N95 antibody, SC1.N135 and antibody SC1.N146 antibody; wherein the SC1.N structures are disclosed within the specification
Patent NZ-615328-A (NZ)
Title: Fusion proteins and combination vaccines comprising haemophilus influenzae protein e and pilin a
Inventor: BLAIS NORMAND
IPC: C12P21/02
Filed: 2012-04-12
Abstract: Disclosed is a fusion protein of formula I: (X)m - (R1)n - A - (Y)o - B - (Z)p (formula I) wherein: X is a signal peptide or MHHHHHH; m is 0 or 1; R1 is an amino acid; n is 0, 1, 2, 3, 4, 5 or 6; A is Protein E from Haemophilus influenzae or an immunogenic fragment thereof, or PilA from Haemophilus influenzae or an immunogenic fragment thereof; Y is selected from the group consisting of GG, SG, SS, GGG and (G)h wherein h is 4, 5, 6, 7, 8,9, or 10; o is 0 or 1; B is PilA from Haemophilus influenzae or an immunogenic fragment thereof, or Protein E from Haemophilus influenzae or an immunogenic fragment thereof; Z is GGHHHHHH (SEQ 10 NO.3); and p is 0 or 1, wherein when A is Protein E from Haemophilus influenzae or an immunogenic fragment thereof, B is not Protein E from Haemophilus influenzae or an immunogenic fragment thereof; and wherein when A is PilA from Haemophilus influenzae or an immunogenic fragment thereof, B is not PilA from Haemophilus influenzae or an immunogenic fragment thereof. Also disclosed is an immunogenic composition comprising isolated Protein E from H. influenzae and isolated PilA from H. influenzae
Patent NZ-620469-A (NZ)
Title: Pyrrolidine-3-ylacetic acid derivative
Inventor: YOSHIDA ICHIRO
IPC: C07D403/12
Filed: 2012-09-11
Abstract: Provided are pyrrolidine-3-yl-acetic acid derivative compounds, of the general formula (1), wherein the variables are as defined in the specification. Examples of the compounds include 2-[(3S,4R)-1-{ [2-chloro-6-(trifluoromethyl)phenyl]methyl} -3-{ [1-(2-fluoropentyl)piperidin-4-yl]carbamoyl} -4-methylpyrrolidin-3-yl]acetic acid and 2-[(3S,4R)-3-{ [(3S)-1-(cyclohex-1-en-1-ylmethyl)pyrrolidin-3-yl]carbamoyl} -1-[(2,6-dichlorophenyl)methyl]-4-methylpyrrolidin-3-yl]acetic acid. The compounds are inhibitors of the fractalkine-CX3CR1 pathway. The compounds may be useful in the treatment of inflammatory bowel diseases, such as ulcerative colitis and Crohn’s disease.
Patent NZ-620590-A (NZ)
Title: Device for layered stacking a support
Inventor: CAVELIUS JÖRG
IPC: B65G57/24
Filed: 2013-06-26
Abstract: A system for automated stacking of packages (1) into a predetermined volume or area (S) is described. The system seeks to reduce time spent aligning packages on a pallet or base. Boxes are transported to their desired location in the volume/area (S) through a system of conveyors (2,11) and robotic pushing arms (13, 14 Fig 2), producing a three dimensional arrangement of like or unlike containers.
Patent NZ-620644-A (NZ)
Title: Drain channel for a tramway track
Inventor: DUBOIS JÉRÔME
IPC: E01B21/02
Filed: 2012-08-02
Abstract: The disclosure relates to a tramway track drainage device comprising a drain channel section (5, 6) provided with two ends, at least one end being provided with a wall (14, 16) closing said end. The device further comprises an opening (41) created in the wall (14, 16) to form an inspection window for a cable connection (80) with a rail (2) and a plug (60,70) for closing said opening (41), removable from inside the drain channel section (5, 6). Further details are discloses including a further orifice (13) for drainage and passage of a cable connected to a track rail.
Patent NZ-624922-A (NZ)
Title: Orally administered corticosteroid compositions
Inventor: PERRETT STEPHEN
IPC: A61P1/04
Filed: 2010-09-30
Abstract: Disclosed is a non-aqueous liquid pharmaceutical composition for oral administration comprising a corticosteroid, a liquid, and a phase change agent dissolved or suspended in said liquid. Upon administration the composition undergoes a change in physical properties upon contact with the gastrointestinal tract of said patient, which prolongs contact of the corticosteroid with the gastrointestinal tract of the patient. the phase change may be the formation of a film on a mucosal surface. The corticosteroid may be, fluticasone and the phase change agent may be ethylcellulose.
Patent NZ-704137-A (NZ)
Title: Systems and methods for inspecting and monitoring a pipeline
Inventor: FREESE ROBERT P
IPC: G01N21/954
Filed: 2013-09-10
Abstract: Systems and methods for inspecting and monitoring an inner surface of a pipeline. One system includes a pig arranged within the pipeline, one or more optical computing devices arranged on the pig adjacent the inner surface of the pipeline for monitoring at least one substance present on the inner surface. The optical computing devices include an electromagnetic radiation source configured to emit electromagnetic radiation that optically interacts with the at least one substance, and at least one integrated computational element configured to optically interact with the at least one substance and thereby generate optically interacted light. The optical computing devices also include a first detector arranged to receive the optically interacted light and generate an output signal corresponding to a characteristic of the at least one substance, and a second detector configured to generate a compensating signal indicative of radiating deviations of the electromagnetic radiation source. A signal processor is communicably coupled to the at least one detector of each optical computing device for receiving the output signal of each optical computing device and determining the characteristic of the at least one substance.
Patent NZ-705201-A (NZ)
Title: A foam-based interfacing structure method and apparatus
Inventor: HOWARD SCOTT ALEXANDER
IPC: A62B9/06
Filed: 2009-09-03
Abstract: A mask to provide a supply of pressurized air to the entrance of the airways of a patient, comprising a frame and an interfacing structure (330). The interfacing structure comprises a clip portion (334) joined to a cushioning component (332). The cushioning component is at least partially constructed from a foam material and arranged to conform to a profile of the patient’s face in the vicinity of an entrance to the patient’s airways. The foam of the cushioning component has a density in the range of 40-70 kg/m3, an indentation force on deflection (“IFD”) hardness at 40% in the range of about 70 to 160N, and an air permeability in the range of 1 to 16 L/min at 40% compression 20 cmH20.
Patent NZ-706641-A (NZ)
Title: Phenolic foam
Inventor: ROCHEFORT MALCOLM
IPC: C08J9/14
Filed: 2013-09-18
Abstract: Phenolic closed-cell foam comprises a hydrocarbon blowing agent and includes an alkali metal silicate in an amount of at least 1% by weight. The foam has an aged thermal conductivity as determined by the procedures of EN13166:2008 of less than 0.025W/m.K. The foam is formed from a phenolic resole resin mixture having a water content of greater than 15% by weight but less than 24% by weight.
Patent NZ-711147-A (NZ)
Title: Antibodies that bind il-23
Inventor: BEIDLER CATHERINE
IPC: A61K39/395
Filed: 2014-03-04
Abstract: The present invention provides a novel antibody that binds to the p19 subunit of human IL-23 and is characterized as having high affinity, selective, and neutralizing properties. The antibody is defined by 6 CDRs as follows; HCDR1: GYKFTRYVMH, HCDR2: YINPYNDGTNYNEKFKG, HCDR3: ARNWDTGL, LCDR1: KASDHILKFLT, LCDR2: GATSLET, LCDR3: QMYWSTPFT. The antibody is useful in the treatment or prevention of an autoimmune or inflammatory condition selected from the group consisting of consisting of multiple sclerosis, rheumatoid arthritis, psoriasis, inflammatory bowel diseases, ankylosing spondylitis, graft- versus-host disease, lupus and metabolic syndrome. The antibody is also useful in the treatment of cancer.
Patent NZ-718056-A (NZ)
Title: Glucosylceramide synthase inhibitors for the treatment of diseases
Inventor: BRIDGES Alexander
IPC: C07D417/12
Filed: 2014-09-19
Abstract: Described herein are compounds of Formula I, methods of making such compounds, pharmaceutical compositions and medicaments containing such compounds, and methods of using such compounds to treat or prevent diseases or conditions associated with the enzyme glucosylceramide synthase (GCS).
Patent NZ-719888-A (NZ)
Title: Curable film-forming compositions comprising catalyst associated with a carrier and methods for coating a substrate
Inventor: MORAVEK SCOTT J
IPC: C09D7/65
Filed: 2014-11-05
Abstract: Coating compositions comprising a film-forming resin and catalyst associated with a carrier, wherein at least some of the catalyst can be released from the carrier upon application of shear force is disclosed. Methods of coating a substrate and substrates coated at least in part with such coatings are also disclosed.
Patent NZ-730056-A (NZ)
Title: Microfluid chip-based, universal coagulation assay
Inventor: BAKHRU SASHA
IPC: B01L3/00
Filed: 2015-09-09
Abstract: A microfluidic, chip-based assay device has been developed for measuring physical properties of an analyte (particularly, whole blood or whole blood derivatives). The technologies can be applied to measure clotting times of whole blood or blood derivatives, determine the effects of anticoagulant drugs on the kinetics of clotting/coagulation, as well as evaluate the effect of anticoagulant reversal agents. These technologies can additionally be used to optimize the dosage of anticoagulation drugs and/or their reversal agents. The assay is independent of the presence of anticoagulant; clotting is activated by exposure of the blood sample in the device to a glass (or other negatively charged material such as oxidized silicon) surface, which activates the intrinsic pathway and can be further hastened by the application of shear flow across the activating materials surface. The absence of chemical activating agents and highly controlled and reproducible micro-environment yields a point of care universal clotting assay.
Patent NZ-739860-A (NZ)
Title: Virtual and augmented reality systems and methods
Inventor: RODRIGUEZ JOSE FELIX
IPC: H04N13/128
Filed: 2016-08-17
Abstract: A virtual or augmented reality display system that controls a display using control information embedded with the virtual or augmented reality imagery that is intended to be shown on the display. The embedded control information can be, for example, one or more substituted or additional bits, pixels, rows or columns in a frame of rendered imagery. The control information can be used to specify one of multiple possible display depth planes. The control information can also specify pixel shifts within a given depth plane or between depth planes. Such a pixel shift may be desirable when displaying rendered imagery, for example, in response to user head movement which has occurred after the image data was already rendered.
Patent NZ-739893-A (NZ)
Title: Fused pyrimidine compound or salt thereof
Inventor: MIYAZAKI ISAO
IPC: C07D487/04
Filed: 2016-09-07
Abstract: The present invention provides a novel RET inhibitor comprising, as an active ingredient, a compound or a salt thereof, and also provides an agent for preventing or treating diseases (e.g., malignant tumors) that can be prevented or treated by RET inhibitory activity. The RET inhibitor comprises, as an active ingredient, a compound represented by Formula (I) or a salts thereof: wherein A, X, and R2 are as defined in the specification.
Patent NZ-745375-A (NZ)
Title: Method and compositions for cellular immunotherapy
Inventor: JENSEN MICHAEL
IPC: C12N15/62
Filed: 2013-08-20
Abstract: The present invention provides nucleic acids, vectors, host cells, methods and compositions for carrying out cellular immunotherapy, such as by adoptively transferring CD8+ T cells or combinations with CD4+ T cell, in which the T cells are genetically modified to express a chimeric receptor. In certain embodiments, the chimeric receptor is encoded by a nucleic acid comprising: (a) a polynucleotide encoding an antibody or antigen-binding fragment thereof that binds to a ROR1, wherein the antibody or antigen-binding fragment thereof binds to an epitope in the Kringle domain of ROR1; (b) a polynucleotide encoding a transmembrane domain; (c) a polynucleotide encoding a polypeptide spacer located between the antibody or antigen-binding fragment thereof and the transmembrane domain, wherein the polypeptide spacer is an immunoglobulin hinge-CH2-CH3 region; and (d) a polynucleotide encoding an intracellular signaling domain that comprises a CD3ζ signaling domain and a co stimulatory domain. Methods for preparing a host cell and pharmaceutical formulations produced by the methods, and methods of using the same, are also described.
Patent NZ-755634-A (NZ)
Title: Sorbent composition and related system and method
Inventor: LUCAS CHRISTOPHER FRANCIS
IPC: B01J20/20
Filed: 2018-01-26
Abstract: The invention relates to a sorbent composition, and a related system and method for contaminant removal. In particular, the invention relates to a sorbent composition for removing one or more chemicals from a liquid, a system including both a sorbent composition and a container for containing the composition, and a method of applying the system to separate and/or remove one or more chemicals from a liquid, for example, from storm water, wastewater, and runoff. The sorbent composition preferably comprises activated charcoal and a non-swelling mineral having an anionic surface comprising hydroxyl groups, such as attapulgite and/or diatomaceous earth.
Patent NZ-759306-A (NZ)
Title: Compositions and methods for reducing flatulence
Inventor: NAGABHUSHANAM KALYANAM
IPC: C12N1/21
Filed: 2018-06-01
Abstract: Disclosed are the methods and compositions for the reduction of intestinal gas/flatulence. Specifically a method for reducing flatulence using a composition containing probiotic bacteria Bacillus coagulans MTCC 5856 is disclosed. More specifically, the invention discloses a method for inhibiting the growth of microorganisms that facilitate the production of intestinal gas, using a composition containing probiotic bacteria Bacillus MTCC 5856.